Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...

In less than a month, Americans will head to the polls—or vote by mail—and elect the next president of the U.S. | While a ...

Earlier this year, Evonik unveiled a restructuring project that will result in up to 2,000 layoffs. | After Evonik in March ...

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...

As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...

A new campaign from Opella, Sanofi’s consumer health unit, is a royal flush. | A new campaign from Opella, Sanofi’s consumer ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...

Thermo Fisher Scientific is responsible for helping to produce some of the hottest drugs on the market, including Novo ...

The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.

Through allocations, Baxter is limiting how much customers can order based on their past purchases, medical necessity and ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...